EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • May 6th, 2021 • Iovance Biotherapeutics, Inc. • Biological products, (no disgnostic substances) • California
Contract Type FiledMay 6th, 2021 Company Industry JurisdictionTHIS EXECUTIVE EMPLOYMENT AGREEMENT (the “Agreement”) is entered into as of February 18, 2021 by and between Iovance Biotherapeutics, Inc., a Delaware corporation (the “Company”), and Igor Bilinsky (“Executive”) (either party individually, a “Party”; collectively, the “Parties”).
EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • February 25th, 2021 • Iovance Biotherapeutics, Inc. • Biological products, (no disgnostic substances) • California
Contract Type FiledFebruary 25th, 2021 Company Industry JurisdictionTHIS EXECUTIVE EMPLOYMENT AGREEMENT (the “Agreement”) is entered into as of November 23, 2020 by and between Iovance Biotherapeutics, Inc., a Delaware corporation (the “Company”), and Jean-Marc Bellemin (“Executive”) (either party individually, a “Party”; collectively, the “Parties”).
EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • November 2nd, 2017 • Iovance Biotherapeutics, Inc. • Biological products, (no disgnostic substances) • California
Contract Type FiledNovember 2nd, 2017 Company Industry JurisdictionTHIS EXECUTIVE EMPLOYMENT AGREEMENT (the “Agreement”) is entered into as of August 4, 2017, by and between Iovance Biotherapeutics, Inc., a Delaware corporation (the “Company”), and Timothy Morris (“Executive”) (either party individually, a “Party”; collectively, the “Parties”).